Mixed response to antiviral drug remdesivir's effectiveness

  1. home
  2. > health
  3. > Mixed response to antiviral drug remdesivir's effectiveness
replay trump newslist
up NEXT IN 5 SECONDS sports newslist
tap to unmute
00:00/00:00
NaN/0

Mixed response to antiviral drug remdesivir's effectiveness

May 04, 2020 11:43 IST

According to the first randomised trial of its kind, researchers say that treatment with antiviral drug remdesivir may not significantly speed up recovery from Covid-19 in critically ill hospitalised patients compared to placebo. The researchers published their findings in the Lancet journal but warn that the study was stopped early after they were unable to recruit enough patients due to the steep decline in cases in China. On the other hand, the US FDA plans to announce an emergency-use authorization of remdesivir for coronavirus treatment according to The New York Times. The drug's make Gilead released its own findings from a different trial which it claimed to be promising.

Health